Pfizer Tokenized Stock (Reality) vs SpaceX (bStocks Tokenized Stock)

SpaceX (bStocks Tokenized Stock) (SPCXB) is 1341.0× the size of Pfizer Tokenized Stock (Reality) (RPFE) by market capitalisation. Their daily returns move closely in opposite directions (correlation -0.78 across 25 shared trading days). SPCXB has been the more volatile of the two, at 73% annualised against RPFE's 26%.

Correlation: -0.78
Size ratio: 1 : 1341.0

Pfizer Tokenized Stock (Reality)RPFE

$29.3600

24h: -4.74%
Market cap: $148,799
Volume 24h: $120,383
Volatility (ann.): 26%

SpaceX (bStocks Tokenized Stock)SPCXB

$127.6800

24h: -5.07%
Market cap: $199.55M
Volume 24h: $61.54M
Volatility (ann.): 73%

RPFE 0.1%Share of the two combined market caps99.9% SPCXB

Performance

RPFESPCXB

7 days+4.71%-12.85%RPFE
30 days+7.06%-27.86%RPFE
90 days—-8.57%—

Correlation

-0.78over 25 shared trading days

−1 opposite0 unrelated+1 in step

7d: insufficient data30d: -0.7890d: insufficient data1y: insufficient data

Measured on daily returns rather than on prices. Two assets that both simply trend upward score near 1.0 on raw prices whether or not they move together, so returns are what answer the question people mean by correlation.

Risk & extremes

Metric	RPFE	SPCXB
Max drawdown (400d)	-4.8%	-47.5%
Risk-adjusted return (90d)	0.27	-0.15

Relative strength over 90 days: RPFE outperformed SPCXB by 14.4% — measured on the RPFE/SPCXB ratio, so it holds regardless of market direction.

Pfizer Tokenized Stock (Reality) →SpaceX (bStocks Tokenized Stock) →